In the multicenter, randomized, placebo-controlled Q-SYMBIO trial, a daily CoQ10 intake of 300mg was found to significantly reduce the incidence of a major adverse cardiovascular event in 15% of subjects (63 out of 420 participants),57 and a 2025 meta-analysis determined that long-term supplementation with doses as low as 100mg significantly reduced users systolic blood pressure.58 IM8 has perhaps too little CoQ10 to make a noticeable difference in, say, heart attack risk, but it seems well-dosed for people looking to alleviate hypertension
[27] However, 3% to 6% of people given intravenous acetylcysteine show a severe, anaphylaxis-like allergic reaction, which may include extreme breathing difficulty (due to bronchospasm), a decrease in blood pressure, rash, angioedema, and sometimes also nausea and vomiting
Cancer Letters , 282 (2), 125136
Increased mitochondrial respiration of adipocytes from metabolically unhealthy obese compared to healthy obese individuals